Xiaobin Wu sold $1.5M of ONC
President and COO at BeOne Medicines Ltd.. 3,991 shares at an average of $380.43, traded Nov 17, 2025, filed Nov 19, 2025.
Score components
- +20RolePresident
- +25Trade size$1.5M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001739452-25-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | SOpen-market sale American Depositary Shares | -3,155 | $380.23 | $1.2M | 836 | Nov 19, 2025 |
| Nov 17, 2025 | SOpen-market sale American Depositary Shares | -826 | $381.19 | $315k | 10 | Nov 19, 2025 |
| Nov 17, 2025 | SOpen-market sale American Depositary Shares | -10 | $382.32 | $3,823 | 0 | Nov 19, 2025 |
Related signals
Other insiders at BeOne Medicines Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeOne Medicines Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 33Weak | BeOne Medicines Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 49Moderate | BeOne Medicines Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 28Weak | ONCsell BeOne Medicines Ltd. | Baker Bros. Advisors LP director | $262k 10,998 shares | -7% | |
| 10Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $102k 341 shares | -100% | |
| 19Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $580k 1,660 shares | -100% | |
| 12Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $220k 664 shares | -100% | |
| 58Moderate | BeOne Medicines Ltd. | John Oyler Chief Executive Officer | $31M 100,000 shares | -100% | |
| 27Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $214k 664 shares | -200% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.